Literature DB >> 6293969

Conversion of leukotriene D4 to leukotriene E4 by a dipeptidase released from the specific granule of human polymorphonuclear leucocytes.

C W Lee, R A Lewis, E J Corey, K F Austen.   

Abstract

Leukotriene D4 (LTD4), the most active spasmogenic leukotriene constituent of the slow reacting substance of anaphylaxis was converted by suspended human polymorphonuclear leucocytes (PMNs) to a single, less polar metabolite which was not further catabolized. This product was identified as leukotriene E4 (LTE4) by its retention time during reverse phase-high performance liquid chromatography (RP-HPLC) and subsequent bioassay on the guinea-pig ileum. LTD4 with a retention time of 21 +/- 1.6 min (mean +/- SD) and a contractile activity of 5.0 +/- 0.4 u./pmol (mean +/- SD) was quantitatively converted extracellularly by PMNs to LTE4 with a retention time of 26 +/- 1.8 min and a contractile activity of 1.2 +/- 0.3 u./pmol. Subcellular fractionations of PMNs revealed the recovered LTD4-to-LTE4 converting activity, termed LTD4 dipeptidase, to be localized only in he granule fraction. There was a time- and calcium-dependent extracellular release of LTD4 dipeptidase in association with lysozyme (r = 0.97, n = 16, P less than 0.001), a constituent of both specific and azurophilic granules, in the absence of release of cytoplasmic lactate dehydrogenase (LDH) and of beta-glucuronidase from the azurophilic granule. Phorbol myristate acetate (PMA), which selectively induces secretion of specific granules, released lysozyme and the LTD4 dipeptidase in a constant dose-dependent manner from PMNs (r = 0.96, n = 8, P less than 0.001). Calcium ionophore A23187 at concentrations less than 10(-7) M stimulated the parallel secretion of LTD4 dipeptidase and lysozyme (r = 0.91, n = 9, P less than 0.005), dipeptidase and lysozyme (r = 0.91, n = 9, P less than 0.005), whereas higher concentrations resulted in secretion of beta-glucuronidase and additional lysozyme without further release of dipeptidase. Thus, human PMNs can convert LTD4 to LTE4, a less vasoactive and spasmogenic leukotriene, via the secretion of a dipeptidase associated with the specific granules.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6293969      PMCID: PMC1453997     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  40 in total

1.  Collagenase is a component of the specific granules of human neutrophil leucocytes.

Authors:  G Murphy; J J Reynolds; U Bretz; M Baggiolini
Journal:  Biochem J       Date:  1977-01-15       Impact factor: 3.857

2.  The neutral proteases of human granulocytes. Isolation and partial characterization of two granulocyte collagenases.

Authors:  K Ohlsson; I Olsson
Journal:  Eur J Biochem       Date:  1973-07-16

3.  Calcium-induced lysozyme secretion from human polymorphonuclear leukocytes.

Authors:  I M Goldstein; J K Horn; H B Kaplan; G Weissmann
Journal:  Biochem Biophys Res Commun       Date:  1974-09-23       Impact factor: 3.575

4.  Association of lactoferrin with lysozyme in granules of human polymorphonuclear leukocytes.

Authors:  M S Leffell; J K Spitznagel
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

5.  Formation of the cysteinyl form of slow reacting substance (leukotriene E4) in human plasma.

Authors:  C W Parker; D Koch; M M Huber; S F Falkenhein
Journal:  Biochem Biophys Res Commun       Date:  1980-12-16       Impact factor: 3.575

6.  Identification of a component of rat mononuclear cell SRS as leukotriene D.

Authors:  M K Bach; J R Brashler; S Hammarström; B Samuelsson
Journal:  Biochem Biophys Res Commun       Date:  1980-04-29       Impact factor: 3.575

Review 7.  A review of recent contributions on biologically active products of arachidonate conversion.

Authors:  R A Lewis; J M Drazen; J C Figueiredo; E J Corey; K F Austen
Journal:  Int J Immunopharmacol       Date:  1982

8.  Cytochalasin B-dependent release of azurophil granule enzymes from human polymorphonuclear leukocytes.

Authors:  E C Yurewicz; M Zimmerman
Journal:  Inflammation       Date:  1977-12       Impact factor: 4.092

9.  Slow reacting substances of anaphylaxis: identification of leukotrienes C-1 and D from human and rat sources.

Authors:  R A Lewis; K F Austen; J M Drazen; D A Clark; A Marfat; E J Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

10.  Characterization of slow reacting substances (SRSs) of rat basophilic leukemia (RBL-1) cells: effect of cysteine on SRS profile.

Authors:  D E Sok; J K Pai; V Atrache; C J Sih
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

View more
  31 in total

1.  Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells.

Authors:  E A Mellor; A Maekawa; K F Austen; J A Boyce
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

2.  Platelet-driven leukotriene C4-mediated airway inflammation in mice is aspirin-sensitive and depends on T prostanoid receptors.

Authors:  Tao Liu; Denise Garofalo; Chunli Feng; Juying Lai; Howard Katz; Tanya M Laidlaw; Joshua A Boyce
Journal:  J Immunol       Date:  2015-04-22       Impact factor: 5.422

3.  GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4.

Authors:  Akiko Maekawa; Barbara Balestrieri; K Frank Austen; Yoshihide Kanaoka
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-26       Impact factor: 11.205

4.  Influence of leukotriene pathway polymorphisms on response to montelukast in asthma.

Authors:  John J Lima; Shu Zhang; Audrey Grant; Lianhe Shao; Kelan G Tantisira; Hooman Allayee; Jianwei Wang; James Sylvester; Janet Holbrook; Robert Wise; Scott T Weiss; Kathleen Barnes
Journal:  Am J Respir Crit Care Med       Date:  2005-11-17       Impact factor: 21.405

5.  High-affinity pan-specific monoclonal antibodies that target cysteinyl leukotrienes and show efficacy in an acute model of colitis.

Authors:  Ashlee N King; Jonathan K Fleming; Stephanie S Knapik; Barbara Visentin; Jonathan M Wojciak; Tom Huxford
Journal:  J Lipid Res       Date:  2017-05-15       Impact factor: 5.922

6.  Leukotriene D4 and cystinyl-bis-glycine metabolism in membrane-bound dipeptidase-deficient mice.

Authors:  G M Habib; Z Z Shi; A A Cuevas; Q Guo; M M Matzuk; M W Lieberman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

7.  Use of high-resolution metabolomics for the identification of metabolic signals associated with traffic-related air pollution.

Authors:  Donghai Liang; Jennifer L Moutinho; Rachel Golan; Tianwei Yu; Chandresh N Ladva; Megan Niedzwiecki; Douglas I Walker; Stefanie Ebelt Sarnat; Howard H Chang; Roby Greenwald; Dean P Jones; Armistead G Russell; Jeremy A Sarnat
Journal:  Environ Int       Date:  2018-08-07       Impact factor: 9.621

8.  Properties of highly purified leukotriene C4 synthase of guinea pig lung.

Authors:  T Yoshimoto; R J Soberman; B Spur; K F Austen
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

Review 9.  Lysophospholipid acyltransferases and leukotriene biosynthesis: intersection of the Lands cycle and the arachidonate PI cycle.

Authors:  Robert C Murphy; Giancarlo Folco
Journal:  J Lipid Res       Date:  2019-01-03       Impact factor: 5.922

10.  Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor.

Authors:  Sailaja Paruchuri; Hiroyuki Tashimo; Chunli Feng; Akiko Maekawa; Wei Xing; Yongfeng Jiang; Yoshihide Kanaoka; Pamela Conley; Joshua A Boyce
Journal:  J Exp Med       Date:  2009-10-12       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.